Barely Significant
← all excerpts

Analytical validation of Gentian NGAL particle-enhanced enhanced turbidimetric immunoassay (PETIA).

Pract Lab Med · 2017 · PMC5575407 · PMID 28856229

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp<0.001actually significant
The BiPorto NGAL Test has also been shown to display a highly significant agreement with the current reference chemiluminescent immunoassay (Abbott Architect NGAL; Abbott Diagnostics, Lake Forest, IL, USA) (r=0.925; p<0.001) [18] . 2.4 Statistics and ethical approval The linearity of the Gentian NGAL assay was tested by calculation of Spearman's correlation coefficient (r) and using Passing and Bablok regression analysis.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.